Head and Neck Mucosal Squamous Cell Carcinoma

Head and Neck Mucosal Squamous Cell Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

457 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 160
Recruiting: 78
Ph III recruiting: 9
Growth YoY: +30%
Industry share: 8%
Top sponsor: National Cancer Institute (NCI)
Termination share: 35.6%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (60)

clinicaltrialsPublishedShowing 451–457 of 457 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00081211	Intratumoral PV701 in Treating Patients With Advanced or Recurrent Unresectable Squamous Cell Carcinoma of the Head and Neck	terminated	Phase 1	30	National Cancer Institute (NCI)NIH	1	Jan 24, 2013	clinicaltrials
NCT00030498	Erlotinib in Treating Patients With Solid Tumors and Liver or Kidney Dysfunction	completed	Phase 1	75	National Cancer Institute (NCI)NIH	1	Jan 16, 2013	clinicaltrials